Biotech

All Articles

ProKidney halts period 3 trial not needed for tissue therapy authorization

.ProKidney has ceased among a set of stage 3 trials for its cell therapy for renal disease after det...

Vaxcyte surges on 'stunning' 31-valent PCV gain against Pfizer

.Vaxcyte introduced what analysts named "impressive" period 1/2 information for its own 31-valent pn...

Recursion's mind health condition test reveals little proof of efficiency

.Recursion has discovered by means of a very early examination of its tech-enabled approach to medic...

Acepodia, Pfizer click with each other for chemistry-based cell treatment

.Call it a case of good chemistry: Acepodia, a biotech based on Nobel Prize-winning scientific resea...

Praxis epilepsy drug lowers confiscations in period 2 trial

.Praxis Preciseness Medicines has actually racked up one more midphase gain in epilepsy this year, w...

Three execs surrender as Dyne posts combined data for DMD applicant

.After running away a professional hold a number of years back, Dyne Therapeutics has actually expos...

Arrowhead fires off phase 3 information in uncommon metabolic disease before market encounter Ionis

.Arrowhead Pharmaceuticals has actually revealed its own give before a potential showdown with Ionis...

Pfizer, Valneva show lyme disease shot efficient for 2nd booster

.Pfizer and Valneva might have regarding pair of additional years to wait just before they make the ...

Fierce Biotech Managing Editor Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Allow's dive into a discussion along with Ayla Ellison, Ferocious Biotech Editor-in-Chief and also ...

New information show how Bayer's asundexian failed to prevent strokes

.Bayer put on hold the phase 3 test for its own factor XIa prevention asundexian behind time in 2013...